Condition-Specific Health
Cogent Biosciences Reports 65% ORR for Bezuclastinib in AdvSM Trial
Phase 3 APEX data presented at EHA 2026 positions the KIT-targeting agent as a potential standard-of-care option in a r…
Condition-Specific Health 84 stories
Condition-Specific Health
Sovleplenib Phase III Data Show Durable Hemoglobin Response in AIHA
HUTCHMED's spleen tyrosine kinase inhibitor advances clinical evidence base as targeted hematology therapies draw renew…
Condition-Specific Health
MagnaWave PEMF Launches M Line With Enhanced Field Control
As PEMF devices edge into recovery and biohacking categories, operator-grade reliability becomes a key differentiator f…
Condition-Specific Health
CB-011 CAR-T Reports 83% Complete Response in Myeloma Trial
Single-dose durability data from EHA 2026 positions off-the-shelf CAR-T as a potential paradigm shift in hematologic on…
Condition-Specific Health
Loma Linda & Nudj Health Launch Whole-Person Primary Care Model
The partnership signals growing institutional appetite for lifestyle-medicine frameworks that embed nutrition and funct…
Condition-Specific Health
Cold Therapy & Breathwork Retreat Market Eyes Nutraceutical Integration
As contrast therapy retreats expand across Europe, finished-formulation brands are eyeing co-marketing and on-site nutr…
Condition-Specific Health
EAA Formulas Gain Ground as Athletes Consolidate Supplement Stacks
The shift reflects consumer fatigue with complex regimens and growing clinical evidence linking complete EAA profiles t…
Condition-Specific Health
Facial Pain Registry Marks First Year With 740 Enrolled
As patient registries expand in pain research, nutraceutical developers gain potential real-world data infrastructure f…
Condition-Specific Health
Fight CRC Expands Climb for a Cure Nationwide on July 18
The expanded virtual format broadens reach for a cause increasingly linked to diet, fiber intake, and gut-health resear…
Condition-Specific Health
Beacon Biosignals Rebrands Sleep Diagnostics Portfolio Under One Name
The move reflects growing operator demand for streamlined sleep-health platforms as the at-home diagnostics category co…
Condition-Specific Health
Gain Therapeutics CEO to Present at Neuro Summit
The clinical-stage biotech is advancing allosteric small molecule therapies — a mechanism drawing growing interest from…
Condition-Specific Health
CONNECTA Therapeutics Advances CTH120 Neuroplasticity Trial
The rare CNS indication sits outside core nutraceutical channels, but neuroplasticity modulation is an emerging mechani…